Hangzhou Biotest Biotech Co Ltd (688767) — Cash Flow Reinvestment Rate
Hangzhou Biotest Biotech Co Ltd (688767) has a Cash Flow Reinvestment Rate of 1.66x as of September 2025, reinvesting CN¥47.02 Million (capex CN¥47.02 Million ) from operating cash flow of CN¥28.39 Million. See 688767 free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Hangzhou Biotest Biotech Co Ltd Cash Flow Reinvestment Rate (2017–2025)
Historical reinvestment intensity for Hangzhou Biotest Biotech Co Ltd across 9 annual periods. For the full cash flow conversion analysis, see Hangzhou Biotest Biotech Co Ltd operating cash flow efficiency.
Annual Cash Flow Reinvestment Rate for Hangzhou Biotest Biotech Co Ltd (2017–2025)
Year-by-year capital reinvestment analysis for Hangzhou Biotest Biotech Co Ltd. See Hangzhou Biotest Biotech Co Ltd (688767) flexibility index to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 3.65x | CN¥388.70 Million | CN¥106.47 Million | CN¥129.87 Million | ▼ -43.9% |
| 2024 | 6.51x | CN¥838.33 Million | CN¥128.83 Million | CN¥245.05 Million | ▲ +553.7% |
| 2023 | 1.00x | CN¥130.79 Million | CN¥131.38 Million | CN¥56.42 Million | ▲ +154.0% |
| 2022 | 0.39x | CN¥275.63 Million | CN¥703.21 Million | CN¥178.92 Million | ▼ -55.5% |
| 2021 | 0.88x | CN¥800.17 Million | CN¥908.12 Million | CN¥200.20 Million | ▲ +245.5% |
| 2020 | 0.26x | CN¥113.76 Million | CN¥446.07 Million | CN¥57.68 Million | ▼ -91.7% |
| 2019 | 3.08x | CN¥78.94 Million | CN¥25.67 Million | CN¥39.47 Million | ▲ +414.0% |
| 2018 | 0.60x | CN¥12.67 Million | CN¥21.17 Million | CN¥12.67 Million | ▼ -83.9% |
| 2017 | 3.73x | CN¥26.37 Million | CN¥7.07 Million | CN¥26.37 Million | — |